Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

Use of Laboratory Markers in Addition to Symptoms for Diagnosis of Inflammatory Bowel Disease in Children: A Meta-analysis of Individual Patient Data.

Holtman GA, Lisman-van Leeuwen Y, Day AS, Fagerberg UL, Henderson P, Leach ST, Perminow G, Mack D, van Rheenen PF, van de Vijver E, Wilson DC, Reitsma JB, Berger MY.

JAMA Pediatr. 2017 Oct 1;171(10):984-991. doi: 10.1001/jamapediatrics.2017.1736.

2.

Fecal S100A12 and fecal calprotectin as noninvasive markers for inflammatory bowel disease in children.

Sidler MA, Leach ST, Day AS.

Inflamm Bowel Dis. 2008 Mar;14(3):359-66.

PMID:
18050298
3.

Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.

Yang Z, Clark N, Park KT.

Clin Gastroenterol Hepatol. 2014 Feb;12(2):253-62.e2. doi: 10.1016/j.cgh.2013.06.028. Epub 2013 Jul 21.

4.

The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease: a systematic review and meta-analysis.

Henderson P, Anderson NH, Wilson DC.

Am J Gastroenterol. 2014 May;109(5):637-45. doi: 10.1038/ajg.2013.131. Epub 2013 May 14. Review.

PMID:
23670113
5.

Fecal calprotectin, MMP-9, and human beta-defensin-2 levels in pediatric inflammatory bowel disease.

Kolho KL, Sipponen T, Valtonen E, Savilahti E.

Int J Colorectal Dis. 2014 Jan;29(1):43-50.

PMID:
24077667
6.

Fecal calprotectin in pediatric inflammatory bowel disease: a systematic review.

Kostakis ID, Cholidou KG, Vaiopoulos AG, Vlachos IS, Perrea D, Vaos G.

Dig Dis Sci. 2013 Feb;58(2):309-19. doi: 10.1007/s10620-012-2347-5. Epub 2012 Aug 17. Review.

PMID:
22899243
7.

Diagnostic test strategies in children at increased risk of inflammatory bowel disease in primary care.

Holtman GA, Lisman-van Leeuwen Y, Kollen BJ, Norbruis OF, Escher JC, Walhout LC, Kindermann A, de Rijke YB, van Rheenen PF, Berger MY.

PLoS One. 2017 Dec 6;12(12):e0189111. doi: 10.1371/journal.pone.0189111. eCollection 2017.

8.

Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.

Langhorst J, Elsenbruch S, Koelzer J, Rueffer A, Michalsen A, Dobos GJ.

Am J Gastroenterol. 2008 Jan;103(1):162-9. Epub 2007 Oct 4.

PMID:
17916108
9.

[Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].

van den Bergh FA, Kolkman JJ, Russel MG, Vlaskamp RT, Vermes I.

Ned Tijdschr Geneeskd. 2003 Nov 29;147(48):2360-5. Review. Dutch.

PMID:
14677476
10.

Faecal calprotectin in suspected paediatric inflammatory bowel disease.

Degraeuwe PL, Beld MP, Ashorn M, Canani RB, Day AS, Diamanti A, Fagerberg UL, Henderson P, Kolho KL, Van de Vijver E, van Rheenen PF, Wilson DC, Kessels AG.

J Pediatr Gastroenterol Nutr. 2015 Mar;60(3):339-46. doi: 10.1097/MPG.0000000000000615.

PMID:
25373864
11.

Accuracy of four fecal assays in the diagnosis of colitis.

Schoepfer AM, Trummler M, Seeholzer P, Criblez DH, Seibold F.

Dis Colon Rectum. 2007 Oct;50(10):1697-706.

PMID:
17762964
12.

Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.

Holtman GA, Lisman-van Leeuwen Y, Kollen BJ, Norbruis OF, Escher JC, Kindermann A, de Rijke YB, van Rheenen PF, Berger MY.

Ann Fam Med. 2016 Sep;14(5):437-45. doi: 10.1370/afm.1949.

13.

The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.

Henderson P, Casey A, Lawrence SJ, Kennedy NA, Kingstone K, Rogers P, Gillett PM, Wilson DC.

Am J Gastroenterol. 2012 Jun;107(6):941-9. doi: 10.1038/ajg.2012.33. Epub 2012 Feb 28.

PMID:
22370604
14.

A meta-analysis of the utility of C-reactive protein, erythrocyte sedimentation rate, fecal calprotectin, and fecal lactoferrin to exclude inflammatory bowel disease in adults with IBS.

Menees SB, Powell C, Kurlander J, Goel A, Chey WD.

Am J Gastroenterol. 2015 Mar;110(3):444-54. doi: 10.1038/ajg.2015.6. Epub 2015 Mar 3. Review.

PMID:
25732419
15.

Fecal calprotectin levels and serological responses to microbial antigens among children and adolescents with inflammatory bowel disease.

Ashorn S, Honkanen T, Kolho KL, Ashorn M, Välineva T, Wei B, Braun J, Rantala I, Luukkaala T, Iltanen S.

Inflamm Bowel Dis. 2009 Feb;15(2):199-205. doi: 10.1002/ibd.20535.

16.

Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay.

Diamanti A, Panetta F, Basso MS, Forgione A, Colistro F, Bracci F, Papadatou B, Francalanci P, Torroni F, Knafelz D, Fina F, Castro M.

Inflamm Bowel Dis. 2010 Nov;16(11):1926-30. doi: 10.1002/ibd.21257.

PMID:
20310017
17.

Rapid fecal calprotectin level assessment and the SIBDQ score can accurately detect active mucosal inflammation in IBD patients in clinical remission: a prospective study.

Voiosu T, Benguş A, Dinu R, Voiosu AM, Bălănescu P, Băicuş C, Diculescu M, Voiosu R, Mateescu B.

J Gastrointestin Liver Dis. 2014 Sep;23(3):273-8. doi: 10.15403/jgld.2014.1121.233.thv.

18.

Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.

Kittanakom S, Shajib MS, Garvie K, Turner J, Brooks D, Odeh S, Issenman R, Chetty VT, Macri J, Khan WI.

Can J Gastroenterol Hepatol. 2017;2017:1450970. doi: 10.1155/2017/1450970. Epub 2017 Apr 16.

19.

Fecal hemoglobin and calprotectin are equally effective in identifying patients with inflammatory bowel disease with active endoscopic inflammation.

Mooiweer E, Fidder HH, Siersema PD, Laheij RJ, Oldenburg B.

Inflamm Bowel Dis. 2014 Feb;20(2):307-14. doi: 10.1097/01.MIB.0000438428.30800.a6.

PMID:
24374878
20.

Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.

Lozoya Angulo ME, de Las Heras Gómez I, Martinez Villanueva M, Noguera Velasco JA, Avilés Plaza F.

Gastroenterol Hepatol. 2017 Mar;40(3):125-131. doi: 10.1016/j.gastrohep.2016.04.009. Epub 2016 May 31. English, Spanish.

PMID:
27260632

Supplemental Content

Support Center